Ceftibuten: another orally active third-generation cephalosporin


    loading  Checking for direct PDF access through Ovid

Abstract

IN BRIEFCeftibuten, an orally active third-generation cephalosporin, appears to be as effective as other commonly used antibacterials in the treatment of respiratory and urinary tract infections in children and adults.It has good activity against a variety of β-lactamase producing Gram-negative organisms and group A streptococci. However, it has little or no activity against Pseudomonas spp. and staphylococci.Ceftibuten appears to be well tolerated, being associated with a lower incidence of diarrhoea than amoxicillin/clavulanic acid.Because of the need to slow the development of antibacterial resistance, and the likely high acquisition cost of this agent, ceftibuten will probably be a second-line choice for most susceptible infections.Third-generation cephalosporins are often used parenterally in the treatment of serious infections. Whether ceftibuten would be useful in parenteral to oral stepdown therapy remains to be determined.

    loading  Loading Related Articles